Trichloroethylene (TCE) is known as a major pollutant that affects both the occupational and general environment. It has been used as an industrial degreasing agent, solvent, and extraction agent for approximately a century. Alternatively, the general population may be exposed to TCE through contaminated drinking water or air. The target organs of TCE include the nervous system, 1iver, kidney, heart, and skin ([@b4-ehp0115-001553]). Among the immunotoxicity end points, evidence for an effect of TCE was strongest for auto-immune disease. Studies in susceptible rodents have shown that TCE exacerbates underlying autoimmune disease, and supporting information comes from multiple human studies of scleroderma and exposure to organic solvents ([@b25-ehp0115-001553]).

Hypersensitivity dermatitis occurring in workers exposed to TCE is completely different from nonspecific skin irritation as a result of defatting action, and the serious consequences of TCE exposure have recently become one of the critical occupational health issues in Asia. The clinical manifestations of TCE exposure include generalized severe dermatitis, fever, abnormal liver function, jaundice, and lymphadenopathy. Skin lesions range from mild multiform erythema to lesions with increasing severity, exfoliative dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis ([@b9-ehp0115-001553]). The literature published in English and ad hoc publications in local languages were reviewed in detail recently by [@b13-ehp0115-001553]. Occurrences of the disease have been reported from the United States, Japan, Spain, Singapore, China, Korea, Thailand, and the Philippines. Most case reports from industrialized countries were published up to 1990, whereas cases from Asian industrializing countries were published later. In the past 10 years, an increasing number of cases of hypersensitivity dermatitis have been reported among TCE-exposed workers from electronic-element plants in Guangdong Province in southern China ([@b11-ehp0115-001553]; [@b13-ehp0115-001553]).

According to epidemiologic surveys in Guangdong Province, \> 200 cases of hypersensitivity dermatitis have been diagnosed, with a prevalence rate of \< 1% among TCE-exposed workers ([@b10-ehp0115-001553]). Epidemiologic studies on patients with TCE-induced hypersensitivity dermatitis reveal that the latency ranges from 6 to 89 days, and a no dose--response relationship was observed ([@b14-ehp0115-001553]). Furthermore, the patch test using TCE and/or its oxidative metabolites among victims was positive ([@b11-ehp0115-001553]).

The incidence of hypersensitivity and autoimmune diseases in industrialized countries has steadily increased over the past three decades ([@b1-ehp0115-001553]), and these diseases are not evenly distributed among countries, regions, or ethnic groups. However, the degree to which genetic and environmental factors influence susceptibility to hypersensitivity and autoimmune diseases is not well defined. One main feature of occupational diseases is relatively defined causative factors, so studies on these diseases are helpful in identifying the role of genetic factors.

One of the best ways to prevent occupational hypersensitivity disease is to identify susceptible biomarkers to use in screening employees before exposure. To date, however, there are no available biomarkers for predicting who among TCE-exposed workers is at high risk of developing hypersensitivity dermatitis. Other factors associated with the disease remain unknown except for human herpes virus 6 reactivation ([@b9-ehp0115-001553]). The genomic region of human leukocyte antigen (HLA) at chromosomal position 6p21 encodes the six classical HLA genes and many other genes that have important roles in the regulation of the immune system as well as in some fundamental cellular processes. The classical class I (HLA-A, HLA-B, and HLA-C) and class II molecules (HLA-DR, HLA-DQ, and HLA-DP) are involved in the control of immune-response mediation of antigen presentation to the T lymphocytes, and play a central role in the immune system by presenting peptides ([@b30-ehp0115-001553]). The HLAs are characterized by an extensive degree of allelic polymorphism; strong associations between hypersensitivity or autoimmune disease and certain *HLA* alleles have been reported, for instance, *HLA-B\*27* and ankylosing spondylitis ([@b3-ehp0115-001553]), and *HLA-B\*1502* and carbamazepine-induced Stevens-Johnson syndrome ([@b6-ehp0115-001553]). Therefore, we hypothesized that the polymorphisms of *HLA* loci might influence the susceptibility of TCE-induced hypersensitivity dermatitis. We conducted a population-based case--control study to investigate this hypothesis.

Materials and Methods
=====================

Study population
----------------

From June 1998 to March 2006, 121 cases with TCE-induced hypersensitivity dermatitis and 142 TCE-tolerant controls were recruited into the case--control study. Both cases and controls were recruited from 80 factories engaged in electronic-element and metal-plating production in Guangdong Province, China. At least one patient was identified in each factory. Controls were defined as the co-workers of the patients with same job title and longer occupational exposure time (\> 90 days) but no skin abnormalities detected by the occupational physicians upon examination. According to data of routine environmental monitoring in the years the cases occurred, the TCE levels in these workplaces ranged from 69 to 790 ppm (median concentration, 90 ppm), which is much higher than the permissible concentration time-weighted average of 5.6 ppm defined by the [@b23-ehp0115-001553]. Compared with the exposure data reviewed by [@b13-ehp0115-001553], the environmental exposure concentrations in the present study were relatively high. All participants were from the southern region of China and were genetically unrelated. Both cases and controls were exposed to TCE in the workplace where they cleaned and degreased metals. The cases were diagnosed with occupational hypersensitivity dermatitis by a panel of occupational physicians according to Chinese National Diagnostic Criteria of Occupational Disease (GBZ38--2002) (2002a). Briefly, on the basis of both TCE exposure history and clinical manifestations (in terms of dermatitis accompanied by fever, lymphadenopathy, and hepatitis), patients were judged to be cases if the onset of symptoms occurred within the first 3 months of TCE exposure. Other potential risk factors, such as medications used and the history of previous skin disease, were excluded during diagnosis.

Four clinical categories were defined among the cases. First, exfoliative dermatitis is characterized by cutaneous fine pink macules and multiorgan involvement (e.g., hepatitis, nephritis) accompanied by systemic manifestations (e.g., fever, eosinophilia, lymphadenopathy, hepatomegaly, splenomegaly) in addition to skin rashes. Second, multiform erythema is characterized by different forms of cutaneous lesions, such as exanthema, blisters, and erythema exsudativum, without mucosal involvement. Third, Stevens-Johnson syndrome is characterized by a rapidly developing blistering exanthema of purpuric macules and target-like lesions accompanied by mucosal involvement. Fourth, toxic epidermal necrolysis is characterized by skin detachment of \> 30% of body surface area. The diagnosis of each case was confirmed by occupational panels. The clinical classification of the disease has been described in detail by [@b13-ehp0115-001553].

The study was approved by the local institutional review board, and informed consent was obtained from all participants.

HLA genotyping
--------------

We obtained genomic DNA from blood by the high-salt method. HLA alleles *HLA-B* \[UniGene accession no. Hs.77961 ([@b31-ehp0115-001553])\], *HLA-DRB1* (UniGene accession no. Hs.654405), *HLA-DQA1* (UniGene accession no. Hs.387679), and *HLA-DQB1* (UniGene accession no. Hs.409934), were determined by sequence-based typing protocols ([@b18-ehp0115-001553]; [@b26-ehp0115-001553]; [@b28-ehp0115-001553]). We then performed bidirectional sequencing. In brief, two reactions were used to obtain sequences of both DNA strands of exon 2 for *HLA-DQA1*, *DQB1*, and *DRB1*, and four reactions were used to obtain sequences of both DNA strands of exon 2 and exon 3 for *HLA-B*. We confirmed ambiguity in equivocal combination results by clone sequencing. We obtained complete sequencing data for 113 cases and 142 controls; because of insufficient DNA quality or quantity, DNA samples from 8 cases were excluded from sequencing.

Comparison of amino acid residues
---------------------------------

We translated the amino acid sequences of 1--182 codons (peptide-binding regions) of *HLA\*B* alleles found in all participants according to the DNA sequence, and compared the amino acid residues of HLA molecules that were positively or nonpositively associated with hypersensitivity disease. We downloaded three-dimensional (3D) HLA homology models from the FIMM website ([@b8-ehp0115-001553]); the structural models were generated by D.R. Flower (Edward Jenner Institute for Vaccine Research, Compton, Berkshire, UK).

Statistical analysis
--------------------

We compared genotype frequencies between groups using Fisher's exact test. To adjust for multiple comparisons, we calculated corrected *p* (*p*~c~) values using Bonferroni's correction for all observed alleles (68 for *HLA-B*, 8 for *HLA-DQA1*, 28 for *HLA-DQB1*, and 78 for *HLA-DRB1*). Therefore, the *p*~c~ value is equal to the *p*-value multiplied by a factor of 1,188,096. Because age and sex were well matched between cases and controls ([Table 1](#t1-ehp0115-001553){ref-type="table"}), the odds ratios (ORs) and their 95% confidence intervals (CIs) were calculated to estimate the relative risk. To accommodate zero count, ORs were calculated with Haldane's modification, which adds the value of 0.5 to each of the cells with zero observation. Hierarchical cluster analysis was used for comparison of amino acid residues encoded by *HLA-B* alleles.

Results
=======

Characteristics of cases and controls
-------------------------------------

The patients typically showed a rash on the extremities, face, neck, or trunk with or without fever within 14--40 days after occupational TCE exposure commenced. The age, sex, exposure duration, and major clinical manifestations are summarized in [Table 1](#t1-ehp0115-001553){ref-type="table"}. Exfoliative dermatitis was the most common clinical manifestation (68.1%; 77/113). We found six cases with Stevens-Johnson syndrome and five cases with toxic epidermal necrolysis; only one case was diagnosed with Stevens-Johnson syndrome in combination with toxic epidermal necrolysis. Because Stevens-Johnson syndrome and toxic epidermal necrolysis are considered to be the same disease but with varying degrees of severity, we grouped them together for further analysis ([@b13-ehp0115-001553]). As shown in [Table 1](#t1-ehp0115-001553){ref-type="table"}, there was no significant difference in distributions of sex and age among these subgroups.

HLA allele frequency
--------------------

Notably, we found that the allele *HLA-B\*1301* was present in 73.5% (83/113) of TCE-induced hypersensitivity dermatitis patients but only in 9.2% (13/142) of TCE-tolerant workers (OR = 27.5; 95% CI, 13.5--55.7; *p*~c~ = 1.48 × 10^−21^). In addition, the *HLA-B\*44* alleles, including *B\*4402* and *B\*4403*, were present in 6.2% (7/113) of cases, whereas in TCE-tolerant workers the alleles were absent ([Table 2](#t2-ehp0115-001553){ref-type="table"}). In contrast, we found no significant association between *HLA-DRB1*, *HLA-DQA1*, or *HLA-DQB1* polymorphisms and the occurrence of TCE-induced hypersensitivity dermatitis (data not shown).

By taking clinical categories into consideration, we found no significant difference in frequencies of *HLA-B\*1301* among the three subgroups (data not shown).

Characteristics of amino acid residues
--------------------------------------

Comparison of 1--182 codons (peptide-binding regions) of 68 *HLA\*B* alleles in all participants showed that HLA-B\*1301 and HLA-B\*44 shared 171 amino acid residues. Hierarchical cluster analysis also showed that HLA-B\*13 and HLA-B\*44 have similar amino acid residues ([Figure 1](#f1-ehp0115-001553){ref-type="fig"}).

Although only three residues were different between HLA-B\*1301 and HLA-B\*1302, only HLA-B\*1301 was related to TCE-induced hypersensitivity dermatitis. The different residues were I^94^I^95^R^97^ (HLA-B\*1301) versus T^94^W^95^T^97^ (HLA-B\*1302). Residue 95 was a component of peptide-binding pocket F. Amino acid residues 73, 77, 80, 81, 84, 95, 116, 118, 123, 124, 143, 146, and 147 constitute pocket F of HLA class I molecules ([@b8-ehp0115-001553]). One different residue was found between HLA-B\*1301 and HLA-B\*1302 (I^95^ vs. W^95^). Between HLA-B\*1301 and HLA-B\*44, there was a difference in residue 116 (L^116^ vs. D^116^). Observations based on HLA 3D homology models showed that residue 95, the bottom of the pocket F, formed a flat structure in W^95^ (tryptophan) but not in I^95^ (isoleucine). In contrast, a similar structure is present between L^116^ and D^116^ ([Figure 2](#f2-ehp0115-001553){ref-type="fig"}).

Discussion
==========

*HLA-B\*13* is one of a common allelic group (phenotype frequency ranges from 10 to 30%) found in the Chinese population, and the distribution of *HLA-B* alleles in the controls of the present study was similar to that of the general population in southern China ([@b7-ehp0115-001553]; [@b15-ehp0115-001553]; [@b29-ehp0115-001553]; [@b33-ehp0115-001553]). In addition, the *HLA-B\*1301* allele, a member of the HLA-*B\*13* group in the southern Chinese population, is a specific allele in Asians, but is absent in whites and blacks ([@b5-ehp0115-001553]; [@b16-ehp0115-001553]; [@b32-ehp0115-001553]). In contrast, *HLA-B\*1302* is the predominant allele of the HLA-*B\*13* group in whites ([@b5-ehp0115-001553]; [@b32-ehp0115-001553]). The frequencies of *HLA-B\*1301* and *HLA-B\*1302* are variably distributed in different regions of China. The frequency of *HLA-B\*1301* in southern Chinese is higher than that in northern Chinese ([@b7-ehp0115-001553]; [@b21-ehp0115-001553]; [@b29-ehp0115-001553]; [@b33-ehp0115-001553]). Rapid economic development, as occurring in China, could generate a highly mobile work force. As such, large numbers of new TCE-exposed workers, combined with genetic features of the population in southern China, may be a major factor in the mass outbreaks of TCE-induced hypersensitivity dermatitis.

The peptides that bind to HLA class I molecules are restricted in length and often contain key amino acids (anchor residues) at certain positions. The side-chains of the peptide anchor residues interact with the polymorphic complementary pockets in HLA peptide-binding grooves and provide the molecular basis for allele-specific recognition of antigenic peptides. HLA polymorphic side-chains delineate the geometry and chemical properties of six structural pockets (A--F) in the groove that can accommodate some of the peptide side-chains. Specifically, the C-terminal side-chain of the peptide, which is lodged in pocket F close to one end of the groove, is important to the stability of the HLA/peptide complex ([@b27-ehp0115-001553]). Comparison of amino acid residues between HLA-B\*1301 and HLA-B\*1302 showed that only three residues (I^94^I^95^R^97^ compared with T^94^W^95^T^97^) were different, and residue 95 is a major component of pocket F. By generating recombinant HLA-B molecules and studying the eluted peptides by mass spectrometry and pool sequencing, [@b2-ehp0115-001553] found that residue 95 causes strong alteration of peptide motifs. According to structure--function analysis, residue I^95^ might play a key role in susceptibility to TCE-induced hypersensitivity dermatitis.

In addition, *HLA-B\*44* was present in 6.2% of cases but was not observed in any of the 142 TCE-tolerant workers. Noticeably, HLA-B\*1301 and HLA-B\*44 shared I^94^I^95^R^97^, which might play a key role in susceptibility to TCE-induced hypersensitivity dermatitis described above. In a previous study that included 15 white patients, [@b24-ehp0115-001553] found that *HLA-B\*44* was associated with the risk of Stevens-Johnson syndrome with ocular involvement; therefore, it is possible that the weak association of *HLA-B\*44* with hypersensitivity dermatitis in TCE-exposed workers is not a chance finding. Certainly, this association should be cautiously considered because of the small number of patients with the *HLA-B\*44* allele.

Recently, strong associations have been reported between a particular *HLA* allele and hypersensitivity dermatitis in patients under treatment with several drugs. Hypersensitivity to abacavir, a nucleoside reverse-transcriptase inhibitor commonly used for anti-AIDS treatment, has been reported to be associated with an *HLA-B* allele (*HLA-B\*5701*) and a haplo-typic *Hsp70-Hom* variant in the HLA region ([@b19-ehp0115-001553]; [@b20-ehp0115-001553]). [@b6-ehp0115-001553] reported a strong association of a specific *HLA-B* allele (*HLA-B\*1502*) in Chinese patients with carbamazepine-induced Stevens-Johnson syndrome. In addition, a significant association was reported between another *HLA-B* allele (*HLA-B\*5801*) and allopurinol-induced cutaneous adverse reactions both in Chinese patients and in European patients ([@b12-ehp0115-001553]; [@b17-ehp0115-001553]). Interestingly, *HLA-B\*1301*, *HLA-B\*1502,* and *HLA-B\*5801*, three common alleles in southern Chinese, shared the residues I^94^I^95^R^97^, which differed from almost all other residues present in all participants. In contrast, *HLA-B\*1302* and *HLA-B\*1501* did not share these residues. Therefore, data from these studies and from the present study suggest that there is a common molecular basis for using *HLA-B\*1301*, *HLA-B\*1502,* and *HLA-B\*5801* as genetic markers for chemical hypersensitivity dermatitis in the Chinese population.

Taken together, these studies suggest that *HLA-B* alleles---alone or together with other genetic polymorphisms in the HLA region---might play a pivotal role in determining individual susceptibility to hypersensitivity dermatitis induced by certain chemicals. Therefore, the mechanism of *HLA-B* involved in severe hypersensitivity dermatitis requires further investigation along these lines.

To our knowledge, this is the first report of the association of the *HLA-B\*1301* allele with human disease, and it is the strongest association between an *HLA* marker and a chemical-related occupational disease described thus far. Potentially, this association could be used to develop a highly reliable screening test to predict high-risk subpopulations to TCE exposure and could be applied for occupational practice to prevent about 70% of the cases of this life-threatening disease. In summary, *HLA-B\*1301* and *HLA-B\*44* might play a crucial role in the pathogenesis of TCE-induced hypersensitivity dermatitis.
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###### 

Demographic data for the cases and controls.

                                   Cases                                                   
  -------------------------------- ------------- ------------- ------------- ------------- -------------
  Age \[years (mean ± SD)\]        22.9 ± 5.41   22.0 ± 4.18   23.7 ± 6.71   22.8 ± 5.28   23.4 ± 5.24
  Male \[no. (%)\]                 32 (41.6)     15 (60.0)     6 (54.5)      53 (46.9)     67 (47.2)
  Female \[no. (%)\]               45 (58.4)     10 (40.0)     5 (45.5)      60 (53.1)     75 (52.8)
  TCE exposure duration (months)   \< 3          \< 3          \< 3          \< 3          \> 3
  Lymphadenopathy \[no. (%)\]      56 (72.7)     17 (68.0)     10 (90.9)     83 (73.5)     0 (0.0)
  Hepatitis \[no. (%)\]            64 (83.1)     20 (80.0)     11 (100.0)    95 (84.0)     0 (0.0)

Abbreviations: ED, exfoliative dermatitis; ME, multiform erythema; SJS, Stevens-Johnson syndrome; TEN, toxic epidermal necrolysis.

###### 

Frequencies of *HLA-B* alleles in cases and controls.

  HLA allele             Cases (*n* = 113)   Controls (*n* = 142)   OR (95% CI)          *p-*Value        *p*~c~
  ---------------------- ------------------- ---------------------- -------------------- ---------------- ----------------
  *B\*1301*              83 (73.5%)          13 (9.2%)              27.5 (13.5--55.7)    1.76 × 10^−27^   1.48 × 10^−21^
  *B\*44*                7 (6.2%)            0 (0.0%)               20.1 ( 2.6--157.5)   0.003            \> 0.05
  *B\*1301* or *B\*44*   89 (78.8%)          13 (9.2%)              36.8 (17.8--76.1)    1.77 × 10^−31^   1.49 × 10^−25^

*p*~c~ Values and ORs were calculated as described in "Materials and Methods."
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